Allworth Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$121K Sell
2,886
-50
-2% -$1.59K ﹤0.01% 1827
2026
Q1
$77.6K Buy
2,936
+875
+42% +$25.6K ﹤0.01% 2018
2025
Q4
$59.7K Buy
2,061
+588
+40% +$17.6K ﹤0.01% 2083
2025
Q3
$40.9K Sell
1,473
-534
-27% -$13.5K ﹤0.01% 2236
2025
Q2
$48.9K Buy
2,007
+251
+14% +$5.5K ﹤0.01% 1958
2025
Q1
$39.4K Sell
1,756
-315
-15% -$7.91K ﹤0.01% 1672
2024
Q4
$56.2K Buy
2,071
+118
+6% +$2.9K ﹤0.01% 1522
2024
Q3
$50K Hold
1,953
﹤0.01% 1407
2024
Q2
$49.6K Sell
1,953
-602
-24% -$15.2K ﹤0.01% 1393
2024
Q1
$73.5K Buy
2,555
+1,659
+185% +$49.9K ﹤0.01% 1131
2023
Q4
$29.4K Sell
896
-529
-37% -$14.4K ﹤0.01% 1421
2023
Q3
$39.7K Buy
1,425
+563
+65% +$18.4K ﹤0.01% 1207
2023
Q2
$29.4K Hold
862
﹤0.01% 1332
2023
Q1
$25.9K Buy
862
+320
+59% +$9.91K ﹤0.01% 1309
2022
Q4
$15.3K Sell
542
-51
-9% -$1.62K ﹤0.01% 1506
2022
Q3
$19K Hold
593
﹤0.01% 1302
2022
Q2
$19K Sell
593
-11
-2% -$385 ﹤0.01% 1253
2022
Q1
$28K Sell
604
-576
-49% -$27.5K ﹤0.01% 1099
2021
Q4
$72K Sell
1,180
-178
-13% -$12.3K ﹤0.01% 758
2021
Q3
$101K Buy
1,358
+806
+146% +$67.6K ﹤0.01% 613
2021
Q2
$51K Hold
552
﹤0.01% 608
2021
Q1
$49K Buy
552
+460
+500% +$45.6K ﹤0.01% 578
2020
Q4
$9K Buy
+92
New +$7.33K ﹤0.01% 855

Other funds holding ARKG

Allworth Financial's ARKG Position: Q2 2026 in Review

Allworth Financial reduced its ARK Genomic Revolution ETF (ARKG) stake by 1.7% in Q2 2026, selling an estimated $1.59K and leaving 2,886 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #1827.

Allworth Financial first reported a position in ARKG in Q4 2020 and has held it in 23 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Allworth Financial held 2,886 shares of ARK Genomic Revolution ETF worth $121K as of Q2 2026.
  • Allworth Financial sold 50 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $1.59K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #1827 holding.
  • Allworth Financial first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 23 quarters since.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.